The Scientist

» stock market

Most Recent

image: Was a Drop in CRISPR Firms’ Stock Warranted?

Was a Drop in CRISPR Firms’ Stock Warranted?

By | June 7, 2017

A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.

5 Comments

image: Another CRISPR Biotech Goes Public

Another CRISPR Biotech Goes Public

By | September 12, 2016

CRISPR Therapeutics, the company started by a pioneer of the gene editing technology, plans to raise $90 million from an initial public offering.

0 Comments

image: Biotech Stocks Take a Hit

Biotech Stocks Take a Hit

By | September 30, 2015

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

1 Comment

image: Biotech Terminates IPO

Biotech Terminates IPO

By | August 15, 2014

The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading. 

0 Comments

image: New Year’s Biotech IPO Boom?

New Year’s Biotech IPO Boom?

By | February 3, 2014

January was a profitable month for biotech companies going public, Burrill & Company says.

5 Comments

image: Week in Review: August 26–30

Week in Review: August 26–30

By | August 30, 2013

New model for neurodevelopment; more biotechs going public; how a virus jumped from mammals to birds; statin side effect linked to genetic variant

0 Comments

image: Biotech IPOs Surge

Biotech IPOs Surge

By | August 23, 2013

The drought has ended for biotech companies seeking to join the public market, but whether this upward swing will last is anybody’s guess.

0 Comments

image: Financial Foraging

Financial Foraging

By | February 4, 2013

Using evolutionary animal behavior theories, researchers find daytime stock traders’ strategies are maladapted.

3 Comments

image: Betting on Biotech

Betting on Biotech

By | April 5, 1993

Despite chill winds on Wall Street, investors continue to place bets on fledgling biotechnology companies.

0 Comments

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. Search for Life on the Red Planet
FreeShip